Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Reginald E. Smith"'
Autor:
Thomas L. Ortel, Susan R. Kahn, Turnly Wong, Christine Demers, Michael J. Kovacs, Scott Kaatz, Reginald E. Smith, David Anderson, Marc A. Rodger, Sam Schulman, Mary Cushman, Jeffrey S. Ginsberg, Susan Solymoss, Isabelle Chagnon, Anat Rabinovich, Suman Rathbun, Lucie Opatrny, Rajendar Hanmiah, Jacqueline M. Cohen, Jareer Kassis, Vicky Tagalakis, P. S. Wells, Alejandro Lazo-Langner, Sylvie Desmarais, Rita Selby, Marie-José Miron, Clive Kearon, Erik Yeo
Publikováno v:
Journal of Thrombosis and Haemostasis. 13:398-408
Summary Background Post-thrombotic syndrome (PTS) is a frequent chronic complication of deep vein thrombosis (DVT). Objective In the BioSOX study, we investigated whether inflammation markers predict the risk of PTS after DVT. Methods We measured C-r
Autor:
Wee-Shian Chan, Evelyne Rey, Nancy E. Kent, Thomas Corbett, Michèle David, M. Joanne Douglas, Paul S. Gibson, Laura Magee, Marc Rodger, Reginald E. Smith
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 36:527-553
Objective To present an approach, based on current evidence, for the diagnosis, treatment, and thromboprophylaxis of venous thromboembolism in pregnancy and postpartum. Evidence Published literature was retrieved through searches of PubMed, Medline,
Autor:
Wee-Shian Chan, Evelyne Rey, Nancy E. Kent, Thomas Corbett, Michèle David, M. Joanne Douglas, Paul S. Gibson, Laura Magee, Marc Rodger, Reginald E. Smith
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 36:554-558
Resume Objectif Presenter une approche, fondee sur les donnees actuelles, envers le diagnostic, la prise en charge et la thromboprophylaxie de la thromboembolie veineuse pendant la grossesse et la periode postpartum. Resultats La litterature publiee
Autor:
Reginald E. Smith, Jehangir Din, Nicholas L. Cruden, Simon D. Robinson, Anthony Della Siega, Ron G. Carere, W. Peter Klinke, Christian Janssen, J. David Hilton
Publikováno v:
American journal of cardiovascular drugs : drugs, devices, and other interventions. 16(2)
Guidelines recommend clopidogrel use for 6–12 months following drug-eluting stent (DES) implantation and 1–12 months following bare metal stent (BMS) implantation. The role of clopidogrel beyond 12 months is unclear. We linked hospital administra
Publikováno v:
American Journal of Cardiovascular Drugs. 9:44-58
Deep vein thrombosis (DVT) and pulmonary embolism (PE) are manifestations of venous thromboembolic events (VTEs). Patients undergoing major surgical procedures such as total hip replacement (THR), total knee replacement (TKR), and hip fracture surger
Autor:
Thomas W. Paton, Carmine Stumpo, Josée Martineau, Susan R. Kahn, George Dranitsaris, Jeffrey S. Ginsberg, Reginald E. Smith
Publikováno v:
American Journal of Cardiovascular Drugs. 4:325-333
Fondaparinux is a novel synthetic antithrombotic that has been evaluated for the prevention of venous thromboembolism (VTE). In four large trials in patients who underwent major hip or knee surgery, fondaparinux was found to have a good safety profil
Publikováno v:
The Annals of pharmacotherapy. 30(5)
OBJECTIVE: To describe a patient who presented with heparin allergy and required alternate anticoagulation for unstable angina and coronary artery bypass surgery. To review therapeutic alternatives to porcine heparin for patients with hypersensitivit
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 53(6)